Elizabeth Perkins, MD

Protein intake, pacing weight loss safely, and remembering that one patient in front of you has one life to live round out a rheumatologist's closing clinical pearls.

A clinician's dosing and nutrition guidance meets a patient's hard-won advice for anyone entering combination therapy: manage expectations, stay engaged with your doctor, and be willing to keep exploring.

Dr. Bakewell and Dr. Perkins highlight new ongoing studies in PsA care and a shrinking medication list with combination approach.

Beyond joint counts and skin scores, the panel examines how combination therapy touched a veteran's mental health, and where cardiac, cognitive, and other comorbidity research is heading next.

Casual observations about benefits of incretin therapy in patients with psoriatic diseases lead to combination therapy approach and TOGETHER-PsA trial.

Obesity affects the majority of patients with psoriatic arthritis and can blunt even the best available biologics, raising the question of weight-based dosing and new treatment tools.

Eight medications, one persistent rash, and a run of trial and error trace the real-world difficulty of matching a psoriatic arthritis patient to the drug that finally works.

Kameillia Welch gives a deeply personal account of how one patient finally reached a diagnosis after years of unexplained pain.

A veteran's decade-long path through psoriatic arthritis and obesity opens the program, setting up a wide-ranging look at diagnosis, treatment, and the disease's true prevalence.